Centaurus Financial’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.32M | Buy |
49,910
+152
| +0.3% | +$23.4K | 0.35% | 66 |
|
|
2025
Q4 | $7.7M | Buy |
49,758
+803
| +2% | +$120K | 0.35% | 66 |
|
|
2025
Q3 | $6.81M | Buy |
48,955
+3,509
| +8% | +$475K | 0.32% | 72 |
|
|
2025
Q2 | $6.13M | Buy |
45,446
+14,718
| +48% | +$1.99M | 0.36% | 62 |
|
|
2025
Q1 | $4.49M | Sell |
30,728
-4,515
| -13% | -$656K | 0.27% | 82 |
|
|
2024
Q4 | $4.85M | Sell |
35,243
-8,573
| -20% | -$1.25M | 0.3% | 73 |
|
|
2024
Q3 | $6.75M | Buy |
43,816
+35
| +0.1% | +$5.3K | 0.43% | 55 |
|
|
2024
Q2 | $6.38M | Sell |
43,781
-19,405
| -31% | -$2.78M | 0.42% | 53 |
|
|
2024
Q1 | $9.34M | Buy |
63,186
+19,650
| +45% | +$2.82M | 0.65% | 31 |
|
|
2023
Q4 | $5.94M | Buy |
43,536
+5,740
| +15% | +$747K | 0.45% | 48 |
|
|
2023
Q3 | $4.87M | Sell |
37,796
-15,475
| -29% | -$2.05M | 0.42% | 55 |
|
|
2023
Q2 | $7.07M | Sell |
53,271
-16,061
| -23% | -$2.12M | 0.62% | 38 |
|
|
2023
Q1 | $8.98M | Sell |
69,332
-14,837
| -18% | -$1.94M | 0.72% | 24 |
|
|
2022
Q4 | $11.4M | Buy |
84,169
+13,402
| +19% | +$1.78M | 1.08% | 11 |
|
|
2022
Q3 | $8.57M | Buy |
70,767
+2,482
| +4% | +$320K | 0.84% | 19 |
|
|
2022
Q2 | $8.76M | Sell |
68,285
-24,323
| -26% | -$3.19M | 0.86% | 19 |
|
|
2022
Q1 | $12.7M | Buy |
92,608
+17,532
| +23% | +$2.32M | 1% | 14 |
|
|
2021
Q4 | $10.6M | Buy |
75,076
+22,737
| +43% | +$3.02M | 0.8% | 19 |
|
|
2021
Q3 | $6.66M | Buy |
52,339
+908
| +2% | +$120K | 0.56% | 34 |
|
|
2021
Q2 | $6.48M | Buy |
51,431
+4,818
| +10% | +$590K | 0.55% | 34 |
|
|
2021
Q1 | $5.44M | Buy |
46,613
+1,623
| +4% | +$187K | 0.54% | 38 |
|
|
2020
Q4 | $5.1M | Buy |
44,990
+870
| +2% | +$95K | 0.54% | 39 |
|
|
2020
Q3 | $4.65M | Buy |
44,120
+2,291
| +5% | +$241K | 0.64% | 35 |
|
|
2020
Q2 | $4.19M | Buy |
41,829
+2,242
| +6% | +$221K | 0.62% | 36 |
|
|
2020
Q1 | $3.51M | Buy |
39,587
+33,008
| +502% | +$3.21M | 0.7% | 29 |
|
|
2019
Q4 | $670K | Sell |
6,579
-2,068
| -24% | -$199K | 0.09% | 247 |
|
|
2019
Q3 | $779K | Buy |
8,647
+547
| +7% | +$49.9K | 0.12% | 204 |
|
|
2019
Q2 | $750K | Buy |
8,100
+7,445
| +1,137% | +$669K | 0.12% | 205 |
|
|
2019
Q1 | $7.14K | Sell |
655
-378
| -37% | -$34.1K | 0.04% | 308 |
|
|
2018
Q4 | $12 | Buy |
1,033
+1,022
| +9,291% | +$92.5K | 0.09% | 183 |
|
|
2018
Q3 | $1.07K | Sell |
11
-17,275
| -100% | -$1.56M | 0.19% | 126 |
|
|
2018
Q2 | $1.44M | Buy |
17,286
+11,419
| +195% | +$946K | 0.2% | 114 |
|
|
2018
Q1 | $478K | Sell |
5,867
-29,721
| -84% | -$2.53M | 0.11% | 205 |
|
|
2017
Q4 | $2.94M | Buy |
+35,588
| New | +$2.93M | 0.76% | 36 |
|
Other funds holding XLV
Centaurus Financial's XLV Position: Q1 2026 in Review
Centaurus Financial increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 0.31% in Q1 2026, buying an estimated $23.4K and bringing the position to 49,910 shares worth $7.32M. The position accounts for 0.35% of the portfolio, ranked #66.
Centaurus Financial first reported a position in XLV in Q4 2017 and has held it in 34 quarters since. The position peaked at $12.7M in Q1 2022. 1,802 funds tracked by Wall St. Rank hold XLV as of Q1 2026.
- Centaurus Financial held 49,910 shares of State Street Health Care Select Sector SPDR ETF worth $7.32M as of Q1 2026.
- Centaurus Financial bought 152 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $23.4K.
- State Street Health Care Select Sector SPDR ETF made up 0.35% of Centaurus Financial's portfolio in Q1 2026, its #66 holding.
- Centaurus Financial first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2017 and has held it in 34 quarters since.
- Centaurus Financial's State Street Health Care Select Sector SPDR ETF position peaked at $12.7M in Q1 2022.
- 1,802 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.
Based on Centaurus Financial's 13F filing for Q1 2026, filed 18 May 2026.